Xylem (XYL) Tops Q2 EPS by 16c ; Offers Outlook

Xylem (NYSE: XYL) reported Q2 EPS of $0.98, $0.16 better than the analyst estimate of $0.82. Revenue for the quarter came in at $1.72 billion versus the consensus estimate of $1.49 billion.

GUIDANCE:

Xylem sees Q3 2023 EPS of $3.50-$3.70, versus the consensus of $3.33.

For earnings history and earnings-related data on Xylem (XYL) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c